# Jones Hill Capital LP 13F holdings Q2 2026: $470 million

Jones Hill Capital LP reported $470 million in 13F securities across 29 positions for the quarter ended June 30, 2026, in a holdings report filed August 13, 2026. Its largest holding was Biomarin Pharmaceutical Inc at $81.9 million, 17.4% of the reported value. Since Q1 2026 it opened 15 new positions and exited 12.

SpecStream is the live web data engine for teams and agents. It reads the SEC's Form 13F data sets each quarter, and this page is that reading, keyed on the manager's CIK and the security's CUSIP. Ask for the managers or the holdings you track, and each new 13F filing arrives in your sheet, CRM, Slack or agent as the SEC publishes it.

- Quarter: Q2 2026, the quarter ended June 30, 2026
- Reported value: $470,359,288
- Positions: 29
- Filed: August 13, 2026
- Report type: 13F holdings report
- CIK: 2102314
- Form 13F file number: 028-26921
- CRD number: 339686
- Business address: 60 Charlton Street Eighth Floor South, New York, NY 10013
- SEC filing: [0002102314-26-000005](https://www.sec.gov/Archives/edgar/data/2102314/000210231426000005/0002102314-26-000005-index.htm)
- Investment adviser record: [Form ADV on SpecStream](https://specstream.ai/data/investment-advisers/firm/jones-hill-capital-lp-339686)

## Top 25 holdings by value

The largest of 29 positions by reported value at the end of the quarter ended June 30, 2026. Put and call options are marked in the class. Change is in shares or principal against the filing for the quarter ended March 31, 2026.

| Issuer | Class | Shares or principal | Value | Change since Q1 2026 |
| --- | --- | --- | --- | --- |
| [Biomarin Pharmaceutical Inc](https://specstream.ai/data/institutional-holders/biomarin-pharmaceutical-inc-09061g101) | COM | 1,431,590 | $81.9 million | +163,200 |
| [Gilead Sciences Inc](https://specstream.ai/data/institutional-holders/gilead-sciences-inc-375558103) | COM | 343,043 | $43.3 million | New |
| [Arcutis Biotherapeutics Inc](https://specstream.ai/data/institutional-holders/arcutis-biotherapeutics-inc-03969k108) | COM | 1,089,701 | $28.6 million | New |
| [Madrigal Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/madrigal-pharmaceuticals-inc-558868105) | COM | 52,545 | $28.2 million | New |
| [Bicara Therapeutics Inc](https://specstream.ai/data/institutional-holders/bicara-therapeutics-inc-055477103) | COM | 892,621 | $26.5 million | -367,515 |
| [Relmada Therapeutics Inc](https://specstream.ai/data/institutional-holders/relmada-therapeutics-inc-75955j402) | COM | 3,655,075 | $25.3 million | +3,312,323 |
| [Trevi Therapeutics Inc](https://specstream.ai/data/institutional-holders/trevi-therapeutics-inc-89532m101) | COM | 1,339,212 | $25 million | +969,037 |
| [Pharvaris N V](https://specstream.ai/data/institutional-holders/pharvaris-n-v-n69605108) | COM | 677,879 | $23.4 million | +510,865 |
| [Xenon Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/xenon-pharmaceuticals-inc-98420n105) | COM | 367,900 | $22.2 million | New |
| [Ani Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/ani-pharmaceuticals-inc-00182c103) | COM | 233,808 | $19.4 million | -84,783 |
| [Immunocore Hldgs PLC](https://specstream.ai/data/institutional-holders/immunocore-hldgs-plc-45258d105) | ADS | 512,856 | $16.3 million | New |
| [Amylyx Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/amylyx-pharmaceuticals-inc-03237h101) | COM | 894,058 | $16.1 million | -704,736 |
| [Insmed Inc](https://specstream.ai/data/institutional-holders/insmed-inc-457669307) | COM PAR $.01 | 122,375 | $13 million | New |
| [Nuvalent Inc](https://specstream.ai/data/institutional-holders/nuvalent-inc-670703107) | COM | 98,442 | $12.2 million | -202,388 |
| [Capricor Therapeutics Inc](https://specstream.ai/data/institutional-holders/capricor-therapeutics-inc-14070b309) | COM NEW | 420,751 | $10.1 million | -488,456 |
| [Aclaris Therapeutics Inc](https://specstream.ai/data/institutional-holders/aclaris-therapeutics-inc-00461u105) | COM | 1,759,492 | $9.3 million | New |
| [Immunic Inc](https://specstream.ai/data/institutional-holders/immunic-inc-4525ep200) | COM NEW | 539,814 | $8.3 million | New |
| [Oric Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/oric-pharmaceuticals-inc-68622p109) | COM | 747,313 | $8.1 million | New |
| [Tonix Pharmaceuticals HLDG C](https://specstream.ai/data/institutional-holders/tonix-pharmaceuticals-hldg-c-890260839) | COM NEW | 625,428 | $8 million | +173,312 |
| [Syndax Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/syndax-pharmaceuticals-inc-87164f105) | COM | 340,000 | $7.4 million | New |
| [Olema Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/olema-pharmaceuticals-inc-68062p106) | COM | 574,166 | $7.2 million | New |
| [Vir Biotechnology Inc](https://specstream.ai/data/institutional-holders/vir-biotechnology-inc-92764n102) | COM | 659,213 | $6.7 million | -539,000 |
| [Corbus Pharmaceuticals Hldgs](https://specstream.ai/data/institutional-holders/corbus-pharmaceuticals-hldgs-21833p301) | COM NEW | 653,572 | $6.1 million | New |
| [Dianthus Therapeutics Inc](https://specstream.ai/data/institutional-holders/dianthus-therapeutics-inc-252828108) | COM | 57,100 | $5.6 million | New |
| [Vertex Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/vertex-pharmaceuticals-inc-92532f100) | COM | 11,123 | $5.5 million | -97,480 |

## New positions in Q2 2026

15 positions not in the filing for the quarter ended March 31, 2026.

| Issuer | Class | Shares or principal | Value |
| --- | --- | --- | --- |
| [Gilead Sciences Inc](https://specstream.ai/data/institutional-holders/gilead-sciences-inc-375558103) | COM | 343,043 | $43.3 million |
| [Arcutis Biotherapeutics Inc](https://specstream.ai/data/institutional-holders/arcutis-biotherapeutics-inc-03969k108) | COM | 1,089,701 | $28.6 million |
| [Madrigal Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/madrigal-pharmaceuticals-inc-558868105) | COM | 52,545 | $28.2 million |
| [Xenon Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/xenon-pharmaceuticals-inc-98420n105) | COM | 367,900 | $22.2 million |
| [Immunocore Hldgs PLC](https://specstream.ai/data/institutional-holders/immunocore-hldgs-plc-45258d105) | ADS | 512,856 | $16.3 million |
| [Insmed Inc](https://specstream.ai/data/institutional-holders/insmed-inc-457669307) | COM PAR $.01 | 122,375 | $13 million |
| [Aclaris Therapeutics Inc](https://specstream.ai/data/institutional-holders/aclaris-therapeutics-inc-00461u105) | COM | 1,759,492 | $9.3 million |
| [Immunic Inc](https://specstream.ai/data/institutional-holders/immunic-inc-4525ep200) | COM NEW | 539,814 | $8.3 million |
| [Oric Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/oric-pharmaceuticals-inc-68622p109) | COM | 747,313 | $8.1 million |
| [Syndax Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/syndax-pharmaceuticals-inc-87164f105) | COM | 340,000 | $7.4 million |
| [Olema Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/olema-pharmaceuticals-inc-68062p106) | COM | 574,166 | $7.2 million |
| [Corbus Pharmaceuticals Hldgs](https://specstream.ai/data/institutional-holders/corbus-pharmaceuticals-hldgs-21833p301) | COM NEW | 653,572 | $6.1 million |
| [Dianthus Therapeutics Inc](https://specstream.ai/data/institutional-holders/dianthus-therapeutics-inc-252828108) | COM | 57,100 | $5.6 million |
| [Phathom Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/phathom-pharmaceuticals-inc-71722w107) | COM | 161,486 | $1.8 million |
| [Achieve Life Science Inc](https://specstream.ai/data/institutional-holders/achieve-life-science-inc-004468500) | COM | 26,760 | $174,743 |

## Positions exited in Q2 2026

12 positions in the filing for the quarter ended March 31, 2026 and not in this one, with the shares and value reported then.

| Issuer | Class | Shares or principal | Value |
| --- | --- | --- | --- |
| [Vaxcyte Inc](https://specstream.ai/data/institutional-holders/vaxcyte-inc-92243g108) | COM | 644,831 | $37.5 million |
| Terns Pharmaceuticals Inc | COM | 521,237 | $27.5 million |
| [Ultragenyx Pharmaceutical in](https://specstream.ai/data/institutional-holders/ultragenyx-pharmaceutical-in-90400d108) | COM | 1,165,557 | $24.4 million |
| [Argenx Se](https://specstream.ai/data/institutional-holders/argenx-se-04016x101) | SPONSORED ADR | 25,995 | $19 million |
| [Fulcrum Therapeutics Inc](https://specstream.ai/data/institutional-holders/fulcrum-therapeutics-inc-359616109) | COM | 1,771,926 | $13.6 million |
| [Nuvation Bio Inc](https://specstream.ai/data/institutional-holders/nuvation-bio-inc-67080n101) | COM CL A | 2,383,031 | $10.2 million |
| [Oruka Therapeutics Inc](https://specstream.ai/data/institutional-holders/oruka-therapeutics-inc-687604108) | COM | 140,843 | $6.9 million |
| [Contineum Therapeutics Inc](https://specstream.ai/data/institutional-holders/contineum-therapeutics-inc-21217b100) | CL A | 513,053 | $6.7 million |
| [Veradermics Inc](https://specstream.ai/data/institutional-holders/veradermics-inc-922967104) | COMMON STOCK | 100,843 | $6.4 million |
| [Entrada Therapeutics Inc](https://specstream.ai/data/institutional-holders/entrada-therapeutics-inc-29384c108) | COM | 374,010 | $4.7 million |
| [Silence Therapeutics PLC](https://specstream.ai/data/institutional-holders/silence-therapeutics-plc-82686q101) | ADS | 301,604 | $1.6 million |
| [Arrivent Biopharma Inc](https://specstream.ai/data/institutional-holders/arrivent-biopharma-inc-04272n102) | COM | 45,809 | $1.1 million |

## Also on SpecStream

- [Jones Hill Capital LP Form 13F filing on EDGAR](https://www.sec.gov/Archives/edgar/data/2102314/000210231426000005/0002102314-26-000005-index.htm)
- [Jones Hill Capital LP investment adviser record (Form ADV)](https://specstream.ai/data/investment-advisers/firm/jones-hill-capital-lp-339686)
- [Largest 13F filers in New York](https://specstream.ai/data/institutional-holdings/state/new-york)
- [Largest institutional managers by 13F value](https://specstream.ai/data/institutional-holdings)
- [Most widely held securities in 13F filings](https://specstream.ai/data/institutional-holders)

Source: [the SEC's Form 13F data sets](https://www.sec.gov/data-research/sec-markets-data/form-13f-data-sets). Public data published by the US Securities and Exchange Commission (US government work). Managers report these holdings themselves in Form 13F, and the SEC does not check or guarantee them. Form 13F lists long positions in US listed equities, some options and convertible notes held at the end of the quarter, and leaves out short positions, cash, most bonds and holdings below the reporting threshold. Values are market values in US dollars as the manager filed them. A manager can ask the SEC to keep some positions confidential for a time. This page uses SEC data and is not endorsed or certified by the SEC.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in New York, New York

- [Surgical supply companies in New York, New York](https://specstream.ai/data/businesses/surgical-supply-companies/new-york-new-york-united-states)
- [Irish pubs in New York, New York](https://specstream.ai/data/businesses/irish-pubs/new-york-new-york-united-states)
- [Building contractors in New York, New York](https://specstream.ai/data/businesses/building-contractors/new-york-new-york-united-states)
- [Preschools in New York, New York](https://specstream.ai/data/businesses/preschools/new-york-new-york-united-states)
- [Escrow companies in New York, New York](https://specstream.ai/data/businesses/escrow-companies/new-york-new-york-united-states)
- [Vocational and technical schools in New York, New York](https://specstream.ai/data/businesses/vocational-and-technical-schools/new-york-new-york-united-states)
